This bill mandates that all over-the-counter and prescription drugs containing ingredients derived from major food allergens or gluten-containing grains must include clear labeling indicating the presence of such ingredients. The labels are required to identify each ingredient and specify the type of gluten-containing grain when applicable, ensuring that this information is presented in a conspicuous and easily understandable manner for consumers.

Failure to comply with these labeling requirements will result in the drug being classified as misbranded, which is a violation of existing food and drug labeling laws. The bill establishes a penalty structure for misbranding, with fines of $500 for a first offense, $1,000 for a second offense, and $2,000 for any subsequent offenses. The Department of Health is tasked with enforcing these provisions and may conduct investigations to verify compliance. This legislation aims to enhance consumer safety for individuals with allergies or gluten sensitivities by promoting informed decision-making regarding drug consumption.